Home›Potassium Phosphate Monobasic Potassium Phosphate Dibasic In›Potassium Phosphate Monobasic Potassium Phosphate Dibasic In + Angiotensin Ii

Does Potassium Phosphate Monobasic Potassium Phosphate Dibasic In Interact with Angiotensin Ii?

Potassium Phosphate Monobasic Potassium Phosphate Dibasic In and Angiotensin Ii have a contraindicated drug interaction according to U.S. FDA drug labeling data. Concurrent use increases risk of severe and potentially fatal hyperkalemia. Avoid use; if unavoidable, closely monitor serum potassium concentrations. The mechanism involves additive potassium-increasing effect. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Contraindicated
Angiotensin Ii Class
Vasoconstrictor
Management
Do not take together
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Potassium Phosphate Monobasic Potassium Phosphate Dibasic In and Angiotensin Ii occurs because additive potassium-increasing effect. Clinically, this means concurrent use increases risk of severe and potentially fatal hyperkalemia. avoid use; if unavoidable, closely monitor serum potassium concentrations. Because of the severity of this interaction, these medications are contraindicated — meaning they should not be taken together under any circumstances. If you are currently taking both, contact your healthcare provider immediately to discuss alternatives.

What To Tell Your Doctor or Pharmacist

If you are taking Potassium Phosphate Monobasic Potassium Phosphate Dibasic In and your doctor is considering prescribing Angiotensin Ii (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask about alternative medications that do not interact with your current regimen
  • Ask how frequently you should be monitored while these are co-prescribed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Potassium Phosphate Monobasic Potassium Phosphate Dibasic In(Potassium Phosphates)+💊 Angiotensin Ii(Angiotensin Ii)

Severity & Interaction Details

⛔
contraindicated
Avoid this combination
FDA labeling lists this pair as contraindicated. The risk outweighs the benefit in nearly all cases.
Severity scale
MinorContra
On record
Yes
Drug A class
—
Drug B class
Vasoconstrictor
Source
NLP:potassium phosphate, monobasic potassium phosphate, dibasic

What this means in plain English

Concurrent use increases risk of severe and potentially fatal hyperkalemia. Avoid use; if unavoidable, closely monitor serum potassium concentrations.

What the FDA label says

"Additive potassium-increasing effect"

📖 Source: NLP:potassium phosphate, monobasic potassium phosphate, dibasic

Share this result:XFacebookWhatsAppReddit
Add more drugs
Check Potassium Phosphate Monobasic Potassium Phosphate Dibasic In and Angiotensin Ii against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.